📅 2026 Update: Recent Advances in Mesothelioma Treatment

Since the original article was published, significant advancements have occurred in the treatment of mesothelioma. Notably, the FDA has approved new combination therapies that improve patient outcomes. The information in the earlier article remains relevant and continues further down the page.

🩺 FDA Approvals of Combination Therapies

In September 2024, the FDA approved Keytruda® (pembrolizumab) for use in combination with pemetrexed and platinum chemotherapy. This treatment is specifically for unresectable advanced or metastatic pleural mesothelioma. The KEYNOTE-483 clinical trial showed that patients receiving this combination had a median overall survival of 17.3 months, compared to 16.1 months for those on chemotherapy alone.

💊 New Immunotherapy Options

The FDA also approved the combination of Opdivo® (nivolumab) and Yervoy® (ipilimumab) as a first-line treatment for inoperable malignant pleural mesothelioma in 2024. Results from the CheckMate 743 trial indicated that patients on this combination experienced a median overall survival of 18.1 months, compared to 14.1 months for chemotherapy alone.

🏥 Updated Surgical Guidelines

The National Comprehensive Cancer Network (NCCN) released new guidelines in 2026 recommending pleurectomy/decortication (P/D) over extrapleural pneumonectomy (EPP) for treating pleural mesothelioma. EPP is now reserved for rare cases, and surgery is no longer listed as an option for stages 2 through 4 of any cell type.

💰 Costs of New Treatments

As of October 2026, the average wholesale price for Keytruda® is approximately $10,000 per 100 mg vial. The costs associated with Opdivo® and Yervoy® are about $7,000 and $1,200 per vial, respectively. Treatment costs will vary based on dosage and insurance coverage.

📌 Key Points Summary

  • 🎉 FDA approved new combination therapies for mesothelioma.
  • 📊 Keytruda® offers median overall survival of 17.3 months.
  • 💡 Opdivo® and Yervoy® combination shows median survival of 18.1 months.
  • ⚖️ NCCN recommends P/D over EPP for surgical treatment.
  • 💵 Treatment costs vary by drug and insurance.

💡 Tips for Navigating Mesothelioma Treatment

Discuss your specific situation with your attorney to ensure you understand your options.

🔍 Understand Eligibility Criteria

Patients should know that eligibility for Keytruda® includes those with unresectable advanced or metastatic pleural mesothelioma and no prior systemic therapy. Similarly, the Opdivo® and Yervoy® combination is for those with inoperable malignant pleural mesothelioma.

🏥 Explore Clinical Trials

Patients may consider enrolling in clinical trials for new mesothelioma treatments. These trials can provide access to cutting-edge therapies and valuable contributions to medical research.

📅 Stay Informed About Treatment Options

Recent studies show that multimodal therapy, which combines surgery, chemotherapy, and radiation, may not always improve survival rates. It is important to understand the latest findings to make informed decisions.

📞 Utilize Available Resources

Organizations like the Mesothelioma Applied Research Foundation and the National Cancer Institute offer support and information. They can help patients understand treatment options and access clinical trials.

💬 Communicate with Healthcare Providers

Regular communication with healthcare providers is essential. Patients should discuss their treatment plans, potential side effects, and any changes in their health status during therapy.

🏆 Free Options Ranked by User Reviews (2026)

No paid national service met the review threshold for this area, so this section highlights free government and nonprofit resources available for mesothelioma patients.

🥇 1. Mesothelioma Applied Research Foundation

This nonprofit organization provides resources, support, and information on mesothelioma. They help patients access clinical trials and offer guidance on treatment options.

🥈 2. National Cancer Institute (NCI)

The NCI offers comprehensive information about mesothelioma. Their resources include details on treatment options, ongoing clinical trials, and support services for patients and families.

🥉 3. National Comprehensive Cancer Network (NCCN)

NCCN publishes guidelines on cancer treatment, including mesothelioma. Their guidelines help healthcare providers and patients make informed decisions about treatment approaches.

4️⃣ Centers for Disease Control and Prevention (CDC)

The CDC provides information on asbestos exposure and its health effects, including mesothelioma. Their resources can help patients understand the risks associated with asbestos.

5️⃣ American Cancer Society

The American Cancer Society offers support and information for individuals affected by cancer, including mesothelioma. They provide resources for treatment options, support groups, and financial assistance.

🔎 What to Check Before Paying for Help

  • 🔍 Review any fees involved in services.
  • 📄 Ensure the organization is reputable and has positive reviews.
  • 🗣️ Confirm what specific services are offered.
  • 📞 Ask about the experience of staff in mesothelioma cases.

❓ Frequently Asked Questions

❓ What are the latest treatments for pleural mesothelioma?

Recent FDA approvals include Keytruda® and the Opdivo® and Yervoy® combination, both showing improved survival rates compared to standard chemotherapy.

💬 How do I know if I qualify for new treatments?

Eligibility for new treatments depends on factors like the stage of mesothelioma and previous therapies. A healthcare provider can evaluate individual cases for eligibility.

💵 What are the costs associated with new mesothelioma therapies?

The average wholesale prices for Keytruda®, Opdivo®, and Yervoy® vary, with Keytruda® costing about $10,000 per 100 mg vial. Costs depend on dosage and insurance coverage.

🔍 Are there clinical trials available for mesothelioma?

Yes, clinical trials are ongoing for various mesothelioma treatments. Patients are encouraged to speak with their healthcare providers about trial options.

🏥 What is the role of surgery in mesothelioma treatment?

Surgery is now recommended selectively, with P/D favored over EPP according to NCCN guidelines. Surgery is not listed as an option for stages 2 through 4.

📞 Where can I find support for mesothelioma?

Support is available through organizations like the Mesothelioma Applied Research Foundation and the National Cancer Institute, which offer resources and assistance.

⚖️ Recent Court Rulings Related to Mesothelioma Cases

Recent court rulings have addressed issues surrounding asbestos exposure and mesothelioma claims, impacting patients' rights and available compensations.

For more information, browse recent rulings in the news section.

End of October 2026 Update






 



What is Combination Therapy?



 

Combination Therapy


 



Combination therapy (also referred to as polytherapy) refers to the use of multiple medications or therapies to fight a disease. Combination therapy is distinct from monotherapy, which utilizes only one treatment option to fight a cancer. Many times, these terms refer to the simultaneous administration of multiple medications to treat a single problem. However, the term is also used to describe other types of therapy that are implemented in a simultaneous fashion. 



Combination therapy may be implemented through the administration of separate drugs, or, where available, by prescribing combination drugs with different dosage levels and active ingredients. Combination therapy is used to treat several diseases, including: tuberculosis, cancer, malaria, HIV/AIDS, mesothelioma and leprosy. The primary benefit of combination therapy is that it will reduce the development of drug resistance, because a tumor or pathogen is less likely to sustain multiple drugs simultaneously. 



 



 



How is Combination Therapy Used to Treat Mesothelioma?



 



 



Combination therapy is employed on mesothelioma patients to destroy the disease’s cancerous tumors with a multi-pronged attack. Typically, combination therapy is prescribed within chemotherapy; the combined effect does not include multiple treatment options, but instead, multiple chemotherapy drugs. Combination chemotherapy consists of the use of multiple chemicals to achieve whole destruction of tumors and cancer cells. For instance, combination chemotherapy may include the act of prescribing different drugs to attack cancer cells at varying stages of growth or different intensities. Utilizing combination chemotherapy will ultimately reduce the likelihood of drug resistance. 



 



 



Combination chemotherapy for mesothelioma cancer is known to improve the survival rate of mesothelioma sufferers. Another advantage of this particular mesothelioma treatment option is that it can be perpetually be adjusted by tinkering with the drugs (and dosages) employed. Unfortunately, combination chemotherapy yields severe side effects, including vomiting, nausea, hair loss and extreme fatigue. 



 



 



Oncologists who implement combination chemotherapy will typically be the individuals who decide on which drugs are implemented in combination chemotherapy. The oncologist’s decision will be based on the kind of mesothelioma cancer, the stage of the cancer, the toxicity of the individual chemicals and the health and the age of the patient. As a general rule, the individual rules in the combination regimen must be effective against their cancer on their own. 



 



 



The most common drugs used in mesothelioma combination chemotherapy are Alimta and Cisplating.